Related Experiment Video

Updated: Sep 21, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

371

Imaging tau pathology in Alzheimer's disease with positron emission tomography: lessons learned from

Alexis Moscoso1,2, Melissa C Wren3,4,5,6, Tammaryn Lashley5,6

  • 1Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Molecular Neurodegeneration
|June 6, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Fluorescence-Activated Cell Sorting-Radioligand Treated Tissue FACS-RTT to Determine the Cellular Origin of Radioactive Signal
12:04

Fluorescence-Activated Cell Sorting-Radioligand Treated Tissue FACS-RTT to Determine the Cellular Origin of Radioactive Signal

Published on: September 10, 2021

2.5K
PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke
12:01

PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke

Published on: June 14, 2018

12.9K

Related Experiment Videos

Last Updated: Sep 21, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

371
Fluorescence-Activated Cell Sorting-Radioligand Treated Tissue FACS-RTT to Determine the Cellular Origin of Radioactive Signal
12:04

Fluorescence-Activated Cell Sorting-Radioligand Treated Tissue FACS-RTT to Determine the Cellular Origin of Radioactive Signal

Published on: September 10, 2021

2.5K
PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke
12:01

PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke

Published on: June 14, 2018

12.9K

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

5.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
5.9K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

244
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
244
Brain Imaging01:14

Brain Imaging

325
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
325

Articles linked to this work by shared authors, journal, and citation graph.

Targeted single-nucleus sequencing of 39,800 neurons reveals extensive low-frequency somatic variants.

bioRxiv : the preprint server for biology·2026

TDP-43 dysfunction induces cryptic circular RNAs in ALS/FTD.

bioRxiv : the preprint server for biology·2026

Atypical Alzheimer disease: a multi-axis framework toward defining heterogeneity.

Nature reviews. Neurology·2026

Alzheimer's disease heterogeneity and co-pathologies: Defining novel targets, biomarkers, modalities, and research methodologies.

Alzheimer's & dementia (New York, N. Y.)·2026

TMEM106B is a selective modulator of TDP-43 pathology in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Brain multiomic profiling identifies tau-related transcriptomic dysregulation in Alzheimer's disease.

Brain communications·2026

In vivo detection of pathologic α- synuclein and TDP-43 in the skin and olfactory mucosa of a patient with Parkinson's disease-like phenotype carrying the p.Thr272Serfs*10 GRN mutation.

Molecular neurodegeneration·2026

The YTHDF proteins modulate Alzheimer's disease-associated brain gene signatures.

Molecular neurodegeneration·2026

Dynamic [18F]PI-2620 recording facilitates prediction of β-amyloid positivity and simultaneous staging of tau and neurodegeneration.

Molecular neurodegeneration·2026

Retromer-targeted therapy for neurodegenerative diseases.

Molecular neurodegeneration·2026

Lipid-driven membrane remodeling engages a lysosome-dependent adaptive repair program during retinal aging.

Molecular neurodegeneration·2026

Advancing a systems-level understanding of neurodegeneration: the BrightFocus Alzheimer's disease research portfolio.

Molecular neurodegeneration·2026

Neuroprotective Effect of Imeglimin Hydrochloride on H2O2-Induced SH-SY5Y Cells.

Central nervous system agents in medicinal chemistry·2026

Associations of serum BDNF and Val66Met (rs6265) BDNF gene polymorphism with depressive symptoms and cognitive performance after ischemic stroke: a prospective cohort study.

Neurologia i neurochirurgia polska·2026

Diagnostic classifications based on cognitive, CSF, and PET biomarkers across ADNI cohorts: cross-sectional and longitudinal variability.

Brain communications·2026

Depressive and anxiety symptom trajectories in psychiatric inpatients with nosocomial infection: a retrospective study from China.

Frontiers in psychiatry·2026

Effects and safety of repetitive transcranial magnetic stimulation on cognitive outcomes in mild cognitive impairment: a systematic review and meta-analysis.

Frontiers in aging neuroscience·2026

Association of the systemic immune-inflammation index with consciousness disturbance in cerebral venous sinus thrombosis: a retrospective cohort study.

Frontiers in immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us